Anti-nuclear Antibody (ANA) Testing Market by End-user and Geography - Forecast and Analysis 2021-2025

  • Published: May 2021
  • Pages: 120
  • SKU: IRTNTR44108

Purchase this report now and if we publish a new version within 90 days, we will send you a free copy.

Safe and Secure SSL Encrypted
  • 2500.00
  • USD

The anti-nuclear antibody (ana) testing market size is expected to grow by $ 362.30 mn and record a CAGR of 7% during 2021-2025.

This post-pandemic anti-nuclear antibody (ana) testing market report has assessed the shift in consumer behavior and has identified and explored the upcoming trends and drivers that the vendors can capitalize on to support prompt business decisions. In this anti-nuclear antibody (ana) testing market analysis report, key drivers such as increasing number of autoimmune diseases have been discussed with emerging growth regions, which will offer immense business opportunities. Our analysts have also identified challenges such as limitations of autoimmune disease diagnostics, which will impede market growth. With these insights, the vendors can recreate their plan of action to obtain growth opportunities in the future.

What will the Anti-nuclear Antibody (ANA) Testing Market Size be in 2021?


Browse TOC and LoE with selected illustrations and example pages of Anti-nuclear Antibody (ANA) Testing Market

 Get Your FREE Sample Now!

Who are the Key Vendors in the Anti-nuclear Antibody (ANA) Testing Market?

The anti-nuclear antibody (ana) testing market forecast report provides insights on complete key vendor profiles and their business strategies to reimage themselves. The profiles include information on the production, competitive landscape, sustainability, and prospects of the leading companies including:

  • Abbott Laboratories
  • Abcam Plc
  • Bio-Rad Laboratories Inc.
  • F. Hoffmann-La Roche Ltd.
  • Immuno Concepts Ltd.
  • Merck KGaA
  • PerkinElmer Inc.
  • Seramun Diagnostica GmbH
  • Thermo Fisher Scientific Inc.
  • Trinity Biotech Plc

Our analysts have extensively outlined successful business strategies deployed by the key vendors in this market research report. The anti-nuclear antibody (ana) testing market is fragmented and the vendors are deploying various organic and inorganic growth strategies to compete in the market.

This anti-nuclear antibody (ana) testing market report further entails segmentations by end-user (Hospitals and Clinical diagnostic laboratories) and geography (North America, Europe, Asia, and ROW). The available actionable insights on the segmentations, in this report, will enable a better understanding of the target audience and changing demand patterns.

To make the most of the opportunities, vendors should focus on fast-growing segments, while maintaining their positions in the slow-growing segments. The anti-nuclear antibody (ana) testing market further offers well-structured marketing strategies to overcome the negative post-COVID-19 impact, if any, on each product and service segment.

Which are the Key Regional Markets for Anti-nuclear Antibody (ANA) Testing Market?


For more insights on the market share of various regions Request for a FREE sample now!

The report offers an up-to-date analysis of the geographical composition of the market. North America will record a fast growth rate during 2021-2025, owing to which the region should offer several growth opportunities to market vendors. The advances in laboratory automation platforms will significantly influence anti-nuclear antibody (ana) testing market growth in this region. From the statistical study of the geographic landscape, you can interpret and understand the competitive intelligence and regional opportunities in store for vendors for 2021-2025.

38% of the market’s growth will originate from North America during the forecast period. US, Germany, France, UK, and Japan are the key markets for anti-nuclear antibody (ana) testing market in the region. This report provides estimations of the contribution of all regions to the growth of the anti-nuclear antibody (ana) testing market size.

Anti-nuclear Antibody (ANA) Testing Market Scope

Report Coverage


Page number


Base year


Forecast period


Growth momentum & CAGR

Accelerate at a CAGR of 7%

Market growth 2021-2025

$ 362.30 million

Market structure


YoY growth (%)


Regional analysis

North America, Europe, Asia, and ROW

Performing market contribution

North America at 38%

Key consumer countries

US, Germany, France, UK, and Japan

Competitive landscape

Leading companies, competitive strategies, consumer engagement scope

Companies profiled

Abbott Laboratories, Abcam Plc, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Immuno Concepts Ltd., Merck KGaA, PerkinElmer Inc., Seramun Diagnostica GmbH, Thermo Fisher Scientific Inc., and Trinity Biotech Plc

Market Dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and future consumer dynamics, market condition analysis for forecast period,

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request for a FREE sample

What are the Key Factors Covered in this Anti-nuclear Antibody (ANA) Testing Market Report?

  • CAGR of the market during the forecast period 2021-2025
  • Detailed information on factors that will drive anti-nuclear antibody (ana) testing market growth during the next five years
  • Precise estimation of the anti-nuclear antibody (ana) testing market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the anti-nuclear antibody (ana) testing market industry across North America, Europe, Asia, and ROW
  • A thorough analysis of the market’s competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of anti-nuclear antibody (ana) testing market vendors

Need a Customized Report? Get in touch

Read More Read Less

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.


Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases


Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts



  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis


  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape
Interested in this report?
Get your FREE sample now!
The anti-nuclear antibody (ana) testing market growth will increase by $128.70 million during 2019-2024.
The anti-nuclear antibody (ana) testing market is expected to grow at a CAGR of 6.77% during 2019-2024.
Technavio has segmented the anti-nuclear antibody (ana) testing market by end user (Hospitals and Clinical diagnostic laboratories) and geographic (North America, Europe, APAC, and ROW).
Abbott Laboratories, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Immunarray Pvt Ltd., Immuno Concepts Ltd., Merck KGaA, PerkinElmer Inc., Seramun Diagnostica GmbH, Thermo Fisher Scientific Inc., Trinity Biotech Plc are a few of the key vendors in the anti-nuclear antibody (ana) testing market.
North America will register the highest growth rate of 36.15% among the other regions. Therefore, the anti-nuclear antibody (ana) testing market in North America is expected to garner significant business opportunities for the vendors during the forecast period.
The key factors driving the anti-nuclear antibody (ana) testing market growth are:
  • Increased prevalence of autoimmune diseases
The anti-nuclear antibody (ana) testing market vendors should focus on grabbing business opportunities from the hospitals segment as it accounted for the largest market share in the base year.
Safe and Secure SSL Encrypted

Single User:

2500 USD

Technavio Get the report (PDF) sent to your email within minutes.

Subscribe & Save

Get lifetime access to our
Technavio Insights

Want to customize this report?

This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer $1000 worth of FREE customization at the time of purchase
Enquire Before Buying
  1. Home
  2. Health Care
  3. Published Report
17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>